Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis.
作者信息
Hirano Ikuo, Dellon Evan S, Falk Gary W, Gonsalves Nirmala P, Furuta Glenn T, Bredenoord Albert J
机构信息
Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.
出版信息
Gastroenterology. 2024 Jan;166(1):1-10. doi: 10.1053/j.gastro.2023.09.004. Epub 2023 Sep 9.
Abstract
摘要
相似文献
1
Ascending to New Heights for Novel Therapeutics for Eosinophilic Esophagitis.嗜酸性食管炎新型疗法迈向新高度
Gastroenterology. 2024 Jan;166(1):1-10. doi: 10.1053/j.gastro.2023.09.004. Epub 2023 Sep 9.
2
Eosinophilic esophagitis: from discovery to effective treatment.嗜酸性食管炎：从发现到有效治疗
Allergy Asthma Proc. 2022 May 1;43(3):175-177. doi: 10.2500/aap.2022.43.220025.
3
An update on Eosinophilic Esophagitis.嗜酸性食管炎的最新进展。
Acta Gastroenterol Belg. 2023 Oct-Dec;86(4):533-542. doi: 10.51821/86.4.12001.
4
Eosinophilic Esophagitis: Lessons Learned from Its Evolution.嗜酸性食管炎：从其演变中汲取的经验教训。
Dig Dis Sci. 2024 Feb;69(2):318-319. doi: 10.1007/s10620-023-08166-y. Epub 2023 Nov 15.
5
Concepts and Controversies in Eosinophilic Esophagitis: What's Coming Down the Pipe?嗜酸性食管炎的概念与争议：未来会怎样？
Gastroenterology. 2024 Mar;166(3):382-395. doi: 10.1053/j.gastro.2023.10.035. Epub 2023 Dec 3.
6
Eosinophilic Esophagitis: What's in a Name?嗜酸性粒细胞性食管炎：名称里有什么含义？
Dig Dis Sci. 2024 Feb;69(2):330-334. doi: 10.1007/s10620-023-08205-8. Epub 2023 Dec 7.
7
[Dysphagia with food impaction: suspected eosinophilic esophagitis].[伴有食物嵌塞的吞咽困难：疑似嗜酸性粒细胞性食管炎]
MMW Fortschr Med. 2024 Mar;166(5):66-67. doi: 10.1007/s15006-024-3661-5.
8
Apparent Increase in Eosinophilic Esophagitis Prevalence May Reflect Delayed Guideline Adoption.嗜酸性食管炎患病率的明显上升可能反映了指南采用的延迟。
Clin Gastroenterol Hepatol. 2024 Apr;22(4):905. doi: 10.1016/j.cgh.2023.07.019. Epub 2023 Aug 6.
9
Eosinophilic Gastrointestinal Disorders.嗜酸性胃肠道疾病
Pediatr Clin North Am. 2017 Jun;64(3):475-485. doi: 10.1016/j.pcl.2017.01.009.
10
A Rare Case of Esophageal Granular Cell Tumor in Eosinophilic Esophagitis.嗜酸性食管炎合并食管颗粒细胞瘤1例罕见病例
Clin Gastroenterol Hepatol. 2024 Mar;22(3):A47-A48. doi: 10.1016/j.cgh.2023.09.009. Epub 2023 Sep 22.
引用本文的文献
1
Eosinophilic Esophagitis without Eosinophils: Do You Want to Mock Me?无嗜酸性粒细胞的嗜酸性食管炎：你想嘲笑我吗？
Inflamm Intest Dis. 2025 Apr 29;10(1):126-134. doi: 10.1159/000546069. eCollection 2025 Jan-Dec.
2
Dupilumab Improves Histopathologic Features in Patients With Eosinophilic Esophagitis: LIBERTY EoE TREET Study Results.度普利尤单抗改善嗜酸性食管炎患者的组织病理学特征：LIBERTY EoE TREET研究结果。
Gastro Hep Adv. 2025 Feb 24;4(6):100646. doi: 10.1016/j.gastha.2025.100646. eCollection 2025.
3
Mepolizumab Improves Histologic Severity as Measured by the EoEHSS in Adolescents and Adults With Eosinophilic Oesophagitis in a Multicenter, Randomised, Double-Blind, Placebo-Controlled Clinical Trial.在一项多中心、随机、双盲、安慰剂对照临床试验中，美泊利单抗可改善嗜酸性食管炎青少年和成人患者经嗜酸性食管炎组织学严重程度评分（EoEHSS）测定的组织学严重程度。
Aliment Pharmacol Ther. 2025 May 29. doi: 10.1111/apt.70216.
4
Italian EoExpert panel recommendation for disease control, switching criteria, and follow-up in eosinophilic esophagitis from pediatric to adult age.意大利嗜酸性粒细胞性食管炎专家小组关于从儿童期到成年期疾病控制、转换标准及随访的建议
Therap Adv Gastroenterol. 2025 May 8;18:17562848251337515. doi: 10.1177/17562848251337515. eCollection 2025.
5
Endoscopic response to topical steroids is associated with a need for fewer future esophageal dilations.内镜对局部类固醇的反应与未来较少需要食管扩张相关。
Dis Esophagus. 2025 May 3;38(3). doi: 10.1093/dote/doaf032.
6
Histologic Response or Endoscopic Normalization After Initial Treatment for Eosinophilic Esophagitis in Children Leads to Less Fibrostenosis over Long-Term Follow-Up.儿童嗜酸性粒细胞性食管炎初始治疗后的组织学反应或内镜下正常化在长期随访中导致较少的纤维狭窄。
Dig Dis Sci. 2025 Apr;70(4):1428-1434. doi: 10.1007/s10620-025-08914-2. Epub 2025 Feb 17.
7
Roads to remission: evolving treatment concepts in type 2 inflammatory diseases.缓解之路：2型炎症性疾病不断发展的治疗理念
EClinicalMedicine. 2025 Jan 8;80:103050. doi: 10.1016/j.eclinm.2024.103050. eCollection 2025 Feb.
8
Assessment of Disease Activity in Eosinophilic Esophagitis: Is It Clinically Relevant or Simply an Amusement for Experts?嗜酸性食管炎疾病活动度评估：它具有临床相关性还是仅仅是专家们的一种消遣？
Inflamm Intest Dis. 2024 Dec 10;10(1):10-17. doi: 10.1159/000542470. eCollection 2025 Jan-Dec.
9
Meta-Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled Trials.荟萃分析：评估嗜酸性食管炎随机对照试验中不同结局的安慰剂率
Aliment Pharmacol Ther. 2025 Jan;61(1):32-43. doi: 10.1111/apt.18382. Epub 2024 Nov 14.
10
Pharmacologic Treatment of Eosinophilic Esophagitis: Efficacious, Likely Efficacious, and Failed Drugs.嗜酸性食管炎的药物治疗：有效、可能有效及无效的药物
Inflamm Intest Dis. 2024 Jul 26;9(1):199-209. doi: 10.1159/000540275. eCollection 2024 Jan-Dec.
本文引用的文献
1
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.度普利尤单抗在成人和青少年嗜酸性食管炎中的应用。
N Engl J Med. 2022 Dec 22;387(25):2317-2330. doi: 10.1056/NEJMoa2205982.
2
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.嗜酸粒细胞性食管炎的临床严重程度指数：制定、共识和未来方向。
Gastroenterology. 2022 Jul;163(1):59-76. doi: 10.1053/j.gastro.2022.03.025. Epub 2022 May 20.
3
Reliability and responsiveness of endoscopic disease activity assessment in eosinophilic esophagitis.内镜下疾病活动评估在嗜酸性粒细胞性食管炎中的可靠性和反应性。
Gastrointest Endosc. 2022 Jun;95(6):1126-1137.e2. doi: 10.1016/j.gie.2022.01.014. Epub 2022 Feb 1.
4
Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus.嗜酸性粒细胞性食管炎治疗研究核心结局集（COREOS）的制定：一项国际多学科共识
Gastroenterology. 2021 Sep;161(3):748-755. doi: 10.1053/j.gastro.2021.04.080. Epub 2021 May 20.
5
Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial.布地奈德混悬液可改善嗜酸性食管炎患者的结局：来自 3 期试验的结果。
Clin Gastroenterol Hepatol. 2022 Mar;20(3):525-534.e10. doi: 10.1016/j.cgh.2021.04.022. Epub 2021 Apr 19.
6
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.STRIDE-II：炎症性肠病（STRIDE）国际研究组织（IOIBD）治疗靶点选择更新：确定炎症性肠病靶向治疗策略的治疗目标。
Gastroenterology. 2021 Apr;160(5):1570-1583. doi: 10.1053/j.gastro.2020.12.031. Epub 2021 Feb 19.
7
Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters.嗜酸细胞性食管炎管理的技术评论：AGA 研究所和过敏免疫实践参数联合工作组的报告。
Gastroenterology. 2020 May;158(6):1789-1810.e15. doi: 10.1053/j.gastro.2020.02.039.
8
AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.美国胃肠病学会与过敏免疫实践参数联合工作组关于嗜酸性食管炎管理的临床指南。
Gastroenterology. 2020 May;158(6):1776-1786. doi: 10.1053/j.gastro.2020.02.038.
9
Advancing patient care through the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).通过嗜酸性粒细胞性胃肠病研究人员联合会（CEGIR）推进患者护理。
J Allergy Clin Immunol. 2020 Jan;145(1):28-37. doi: 10.1016/j.jaci.2019.11.012. Epub 2019 Nov 20.
10
Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis.嗜酸性粒细胞性食管炎中食管黏膜下活动的临床相关性。
J Gastroenterol. 2020 Mar;55(3):249-260. doi: 10.1007/s00535-019-01624-3. Epub 2019 Sep 12.
Zotero 插件